CytoMed Therapeutics Limited Ordinary Shares (GDTC)

CytoMed Therapeutics Limited Ordinary Shares (GDTC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $11.1M; returns 1 day +0.0%, 1 week +4.4%, 1 year -62.2%.

CytoMed Therapeutics Limited is a Singapore-based clinical-stage biopharmaceutical company specializing in the development of novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases.

Groups GDTC belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Oncology
• Immunotherapy
• Singapore
• Regenerative Medicine
• Life Sciences
• Healthcare
• Clinical Stage
• Biologics
• Healthcare Technology

GDTC financial model: income statement, cash flow and balance sheet